Use + Remix

patent, copyright and trademark

Companies such as Novartis, led by CEO Vasant Narasimhan, are making moves to counter the generic drug market. (CC BY 2.0) : UNCTAD Photo/Jean Marc Ferré, Wikimedia Commons https://bit.ly/3azO4TR CC BY 2.0

China’s muscling into the pharmaceutical industry, helping Big Pharma bite back against generics. But its global ambitions might turn the industry upside down.

Who owns IP

China’s Big Pharma bet could change the IP game

China’s muscling into the pharmaceutical industry, helping Big Pharma bite back against generics. But its global ambitions might turn the industry upside down.

Law
State leaders such as US President Joe Biden (left) and pharmaceutical heads such as Pfizer CEO Albert Bourla (right) will shape the IP policy of the future. : The White House/Adam Schultz, Wikimedia Commons CC BY 4.0

IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?

Who owns IP

Less talk, more action needed to reform IP for all

IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?

Law
Multiple vaccines for COVID-19 were produced faster than any other in human history under the current legal arrangements. : PMO Barbados, Flickr. CC BY 4.0

Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.

Who owns IP

Patent waiver is no silver bullet, even during COVID-19

Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.

Law